ReviewPharmaceuticals (Basel, Switzerland)2025
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors.
Christine Tran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it